Centre for Blood Research, University of British Columbia, Vancouver BC V6T 1Z3, Canada.
Biomaterials. 2013 Aug;34(25):6068-81. doi: 10.1016/j.biomaterials.2013.04.043. Epub 2013 May 17.
Biodegradable multi-functional polymeric nanostructures that undergo controlled degradation in response to physiological cues are important in numerous biomedical applications including drug delivery, bio-conjugation and tissue engineering. In this paper, we report the development of a new class of water soluble multi-functional branched biodegradable polymer with high molecular weight and biocompatibility which demonstrates good correlation of in vivo biodegradation and in vitro hydrolysis. Main chain degradable hyperbranched polyglycerols (HPG) (20-100 kDa) were synthesized by the introduction of acid labile groups within the polymer structure by an anionic ring opening copolymerization of glycidol with ketal-containing epoxide monomers with different ketal structures. The water soluble biodegradable HPGs with randomly distributed ketal groups (RBHPGs) showed controlled degradation profiles in vitro depending on the pH of solution, temperature and the structure of incorporated ketal groups, and resulted in non-toxic degradation products. NMR studies demonstrated the branched nature of RBHPGs which is correlating with their smaller hydrodynamic radii. The RBHPGs and their degradation products exhibited excellent blood compatibility and tissue compatibility based on various analyses methods, independent of their molecular weight and ketal group structure. When administered intravenously in mice, tritium labeled RBHPG of molecular weight 100 kDa with dimethyl ketal group showed a circulation half life of 2.7 ± 0.3 h, correlating well with the in vitro polymer degradation half life (4.3 h) and changes in the molecular weight profile during the degradation (as measured by gel permeation chromatography) in buffer conditions at 37 °C. The RBHPG degraded into low molecular weight fragments that were cleared from circulation rapidly. The biodistribution and excretion studies demonstrated that RBHPG exhibited significantly lower tissue accumulation and enhanced urinary and fecal excretion when compared to non-degradable HPG of similar molecular weight. Excellent biocompatibility together with in vivo degradability and clearance of RBHPGs make them attractive for the development of multi-functional drug delivery systems.
可生物降解的多功能聚合物纳米结构,能够对生理信号做出可控降解反应,在众多生物医学应用中都十分重要,包括药物输送、生物偶联和组织工程。在本文中,我们报告了一类新型水溶性多功能支化可生物降解聚合物的发展,该聚合物具有高分子量和生物相容性,其体内降解与体外水解具有良好的相关性。主链可降解超支化聚甘油(HPG)(20-100 kDa)是通过在聚合物结构中引入酸性不稳定基团,由环氧丙烷与含有缩酮的环氧化物单体的阴离子开环共聚合成的,其中环氧丙烷单体的结构中含有不同的缩酮结构。具有随机分布缩酮基团的水溶性可生物降解 HPG(RBHPG)在体外表现出可控的降解特性,这取决于溶液的 pH 值、温度以及所引入缩酮基团的结构,并且产生的降解产物无毒性。NMR 研究证明了 RBHPG 的支化特性,这与其较小的流体力学半径有关。RBHPG 及其降解产物表现出优异的血液相容性和组织相容性,这与其分子量和缩酮基团结构无关。当在小鼠体内静脉注射时,具有二甲基缩酮基团的分子量为 100 kDa 的氚标记 RBHPG 的循环半衰期为 2.7±0.3 h,与体外聚合物降解半衰期(4.3 h)以及在 37°C 缓冲条件下的降解过程中分子量分布的变化(通过凝胶渗透色谱法测量)非常吻合。RBHPG 降解为低分子量片段,这些片段能迅速从循环系统中清除。生物分布和排泄研究表明,与具有相似分子量的不可降解 HPG 相比,RBHPG 的组织积累明显更低,并且尿液和粪便排泄增加。RBHPG 具有出色的生物相容性以及体内可降解性和清除率,使其成为多功能药物输送系统的有吸引力的候选材料。